In the s.c. model, ML323 administration reduced ID1 expression in TAMs and manifested a marked tumor inhibition effect, as shown by the tumor volume and tumor weight compared with the vehicle group (Fig. 7a, b; Supplementary Fig. 6a–c). This evidence concerns the gene ID1 and neoplasm.